PACS Group Reports 30% Revenue Growth to $1.03 Billion, Net Income Declines

PACS Group, Inc. reported significant financial performance in its latest 10-Q filing for the quarter ending September 30, 2024, with total revenue reaching $1.03 billion, a 30% increase from $789.2 million in the same period last year. The company's patient and resident service revenue, which constitutes the majority of its income, rose by 29.8% to $1.02 billion, driven by a 21% increase in patient days and a 23.6% growth in operational beds. However, net income for the quarter decreased to $16.2 million, down 18.7% from $19.9 million in the prior year, primarily due to increased operating expenses.

Comparatively, PACS Group's operating expenses surged by 33.3% to $1.00 billion, influenced by a $211.1 million rise in the cost of services, largely attributed to increased salaries and wages as the company expanded its facility count from 201 to 276. General and administrative expenses also saw a notable increase of 42.4%, reflecting costs associated with stock-based compensation and operational growth. The company’s operating income fell by 36.9% to $22.9 million, highlighting the impact of rising costs on profitability.

Strategically, PACS Group has been active in expanding its operations, acquiring 32 skilled nursing and 21 assisted living facilities in September 2024, which added 2,511 skilled nursing beds and 1,334 assisted living beds. This acquisition, part of a broader strategy to enhance its portfolio, was financed through a combination of cash reserves and proceeds from its recent IPO, which raised $423 million. The company also reported a bargain purchase gain of $17.2 million from this acquisition, indicating effective integration of new facilities.

Operationally, PACS Group's total number of facilities increased to 276, with a total of 27,467 skilled nursing beds and 2,244 assisted living beds as of September 30, 2024. The company reported a high occupancy rate of 90.5% across its facilities, slightly up from 90.4% a year earlier. However, new facilities experienced lower occupancy rates, reflecting the transitional challenges associated with recent acquisitions. The company continues to focus on improving clinical quality and operational efficiency, which it believes will enhance its market position.

Looking ahead, PACS Group anticipates continued revenue growth driven by its acquisition strategy and operational improvements. However, the company faces challenges, including rising operational costs and regulatory scrutiny, which could impact future profitability. The management has acknowledged material weaknesses in its internal controls over financial reporting, which they are actively working to address. The company remains optimistic about leveraging its expanded portfolio to drive future growth while navigating the complexities of the healthcare landscape.